Clinical Trial Update: GM-CSF for Immunomodulation Following Trauma (GIFT) Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on GM-CSF for immunomodulation following trauma in pediatric patients is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Injury in Children

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)

Snippet

Sponsor: Mark Hall | Conditions: Critical Injury (Trauma) in Children | Phase 4 | Status: COMPLETED